• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿片受体拮抗剂可改善代谢恢复,并限制大鼠全脑缺血后再灌注相关的神经化学改变。

Opiate-receptor antagonist improves metabolic recovery and limits neurochemical alterations associated with reperfusion after global brain ischemia in rats.

作者信息

Faden A I, Shirane R, Chang L H, James T L, Lemke M, Weinstein P R

机构信息

Department of Neurology, University of California, San Francisco.

出版信息

J Pharmacol Exp Ther. 1990 Nov;255(2):451-8.

PMID:2243336
Abstract

Opiate-receptor antagonists improve behavioral, electrophysiologic and/or histologic outcome in various experimental models of central nervous system ischemia. To address the potential mechanism(s) by which opiate-receptor antagonists may exert their protective actions in cerebral ischemia, metabolic and biochemical changes were measured in brain of rats pretreated with the opiate-receptor antagonist nalmefene or vehicle and subjected to 60 min of global ischemia followed by 2 hr of reperfusion. 31P and 1H magnetic resonance spectroscopy were used to follow the metabolic changes during ischemia and reperfusion, after which brain tissue was frozen in situ. Biochemical assays included free fatty acids, thromboxane B2, ascorbate, vitamin E and amino acids. Nalmefene-treated animals showed more rapid and complete recovery of cellular bioenergetic state (as indicated by the phosphocreatine to inorganic phosphate ratio), tissue acidosis and lactate levels during reperfusion than placebotreated controls. Ischemia/reperfusion caused significant increases of fatty free acids and thromboxane, associated with significant decreases of ascorbate and glutamate; nalmefene pretreatment limited each of these changes. The degree of metabolic improvement as reflected by recovery of high energy phosphates and reduction of lactic acidosis were highly correlated with changes in tissue levels of arachidonate and glutamate. Thus, the beneficial effects of opiate-receptor antagonists in cerebral ischemia may be due, in part, to an ability to enhance metabolic recovery with associated, reduction in phospholipid hydrolysis and excitotoxin release.

摘要

阿片受体拮抗剂可改善各种中枢神经系统缺血实验模型中的行为、电生理和/或组织学结果。为了探究阿片受体拮抗剂在脑缺血中发挥保护作用的潜在机制,我们对预先用阿片受体拮抗剂纳美芬或赋形剂处理的大鼠进行了实验,使其经历60分钟的全脑缺血,随后再灌注2小时,然后测量其大脑中的代谢和生化变化。利用磷-31和氢-1磁共振波谱来跟踪缺血和再灌注期间的代谢变化,之后将脑组织原位冷冻。生化检测包括游离脂肪酸、血栓素B2、抗坏血酸、维生素E和氨基酸。与接受安慰剂处理的对照组相比,接受纳美芬处理的动物在再灌注期间细胞生物能状态(以磷酸肌酸与无机磷酸盐的比率表示)、组织酸中毒和乳酸水平的恢复更快且更完全。缺血/再灌注导致游离脂肪酸和血栓素显著增加,同时抗坏血酸和谷氨酸显著减少;纳美芬预处理限制了这些变化中的每一种。高能磷酸盐的恢复和乳酸酸中毒的减轻所反映的代谢改善程度与花生四烯酸和谷氨酸组织水平的变化高度相关。因此,阿片受体拮抗剂在脑缺血中的有益作用可能部分归因于其增强代谢恢复的能力,以及相关的磷脂水解和兴奋性毒素释放的减少。

相似文献

1
Opiate-receptor antagonist improves metabolic recovery and limits neurochemical alterations associated with reperfusion after global brain ischemia in rats.阿片受体拮抗剂可改善代谢恢复,并限制大鼠全脑缺血后再灌注相关的神经化学改变。
J Pharmacol Exp Ther. 1990 Nov;255(2):451-8.
2
Effects of hyperglycemia on the time course of changes in energy metabolism and pH during global cerebral ischemia and reperfusion in rats: correlation of 1H and 31P NMR spectroscopy with fatty acid and excitatory amino acid levels.高血糖对大鼠全脑缺血及再灌注期间能量代谢和pH值变化时间进程的影响:1H和31P核磁共振波谱与脂肪酸及兴奋性氨基酸水平的相关性
J Cereb Blood Flow Metab. 1992 May;12(3):456-68. doi: 10.1038/jcbfm.1992.63.
3
Effect of dichloroacetate on recovery of brain lactate, phosphorus energy metabolites, and glutamate during reperfusion after complete cerebral ischemia in rats.二氯乙酸对大鼠全脑缺血再灌注期间脑乳酸、磷能量代谢物及谷氨酸恢复的影响。
J Cereb Blood Flow Metab. 1992 Nov;12(6):1030-8. doi: 10.1038/jcbfm.1992.140.
4
Levels of endogenous opioids and effects of an opiate antagonist during regional cerebral ischemia in rats.大鼠局部脑缺血期间内源性阿片类物质水平及阿片拮抗剂的作用
J Pharmacol Exp Ther. 1988 Dec;247(3):1248-54.
5
ATP and pH predictors of histologic damage following global cerebral ischemia in the rat.大鼠全脑缺血后组织学损伤的ATP和pH预测指标
Acta Physiol Hung. 1994;82(2):109-24.
6
Opiate-receptor antagonist nalmefene improves neurological recovery after traumatic spinal cord injury in rats through a central mechanism.阿片受体拮抗剂纳美芬通过中枢机制改善大鼠创伤性脊髓损伤后的神经功能恢复。
J Pharmacol Exp Ther. 1988 May;245(2):742-8.
7
Effects of the new eburnamenine derivative RU 24722 on EEG recovery and cerebral energy metabolism after complete ischemia.新型长春胺衍生物RU 24722对完全性缺血后脑电图恢复及脑能量代谢的影响
Arzneimittelforschung. 1985;35(2):472-7.
8
Dihydropyridine calcium antagonists reduce the consumption of high-energy phosphates in the rat brain. A study using combined 31P/1H magnetic resonance spectroscopy and 31P saturation transfer.二氢吡啶类钙拮抗剂可降低大鼠脑内高能磷酸盐的消耗。一项采用31P/1H磁共振波谱和31P饱和转移联合技术的研究。
J Pharmacol Exp Ther. 1989 Nov;251(2):700-6.
9
Effect of the calcium entry blocker nimodipine on the metabolism of nucleic acids in rat brain ischemia.钙通道阻滞剂尼莫地平对大鼠脑缺血时核酸代谢的影响。
Adv Neurol. 1990;52:133-9.
10
Opiate antagonist nalmefene improves intracellular free Mg2+, bioenergetic state, and neurologic outcome following traumatic brain injury in rats.阿片类拮抗剂纳美芬可改善大鼠创伤性脑损伤后的细胞内游离镁离子水平、生物能量状态及神经功能转归。
J Neurosci. 1990 Nov;10(11):3524-30. doi: 10.1523/JNEUROSCI.10-11-03524.1990.

引用本文的文献

1
The science of cerebral ischemia and the quest for neuroprotection: navigating past failure to future success.脑缺血科学与神经保护探索:从失败中寻找未来成功的路径。
J Neurosurg. 2013 May;118(5):1072-85. doi: 10.3171/2012.11.JNS12408. Epub 2013 Jan 18.
2
Pathobiology of dynorphins in trauma and disease.强啡肽在创伤和疾病中的病理生物学
Front Biosci. 2005 Jan 1;10:216-35. doi: 10.2741/1522.
3
Limiting neurological damage after stroke: a review of pharmacological treatment options.限制中风后的神经损伤:药物治疗选择综述
Drugs Aging. 1999 Jan;14(1):11-39. doi: 10.2165/00002512-199914010-00002.
4
Hypoglycemia prevents increase in lactic acidosis during reperfusion after temporary cerebral ischemia in rats.低血糖可防止大鼠短暂性脑缺血再灌注期间乳酸酸中毒的增加。
NMR Biomed. 1995 Jun;8(4):171-8. doi: 10.1002/nbm.1940080406.